The LDN 2021 Conference Recordings Now Available with up to 29 CME Credits [More Details]

Medical Professionals Become an LDN Specialist [More Details]

Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice

CNS Neurosci Ther
21 May 2021

Preclinical and clinical studies into the bioactivity of low-dose naltrexone (LDN) for oncotherapy

Int Immunopharmacol
11 May 2021

Utilization of Low-Dose Naltrexone for Burning Mouth Syndrome: A Case Report

A A Pract
17 May 2021

Efficacy and safety of low-dose naltrexone in painful diabetic neuropathy: A randomized, double-blind, active-control, crossover clinical trial

J Diabetes
20 May 2021

Reported Benefits of Low-Dose Naltrexone Appear to Be Independent of the Endogenous Opioid System Involving Proopiomelanocortin Neurons and Beta-Endorphin

24 May 2021

Katie, LDN, Fibromyalgia, pain, fatigue and brain fog (Low dose naltrexone) from LDN Research Trust on Vimeo.

Katie takes Low Dose Naltrexone to help with symptoms of Fibromyalgia, pain, fatigue and brain fog.

Addiction Medication Promising for Chronic, Refractory Pain (News)

Submitted by baileylynn_100964 on Sun, 05/02/2021 - 00:28

Addiction Medication Promising for Chronic, Refractory Pain

Medscape Medical News
01 May 2021

Preliminary data from a retrospective chart review of patients with chronic pain showed those who received LDN experienced significant improvement in both pain and disability.


LDN And Rheumatoid Arthritis (News)

Submitted by baileylynn_100964 on Fri, 04/02/2021 - 18:01

LDN And Rheumatoid Arthritis

30 March 2021

Reports from 23andme/CureTogether suggest that LDN (low dose naltrexone) is among the most effective and potent treatments for Rheumatoid Arthritis. Regular and consistent consumption of LDN significantly reduced the need to use other painkillers and disease modifying drugs among Rheumatoid Arthritis patients.